What to Expect When Accessing Care Through Eden
Discover what to expect when accessing metabolic health care through Eden. Learn how Eden connects you with licensed providers and personalized treatment options.
Curious about semaglutide after gastric sleeve? Explore how patients work with licensed providers to determine eligibility for GLP-1 therapy following bariatric surgery.
Gastric sleeve surgery, or vertical sleeve gastrectomy, is a widely performed bariatric procedure aimed at long-term weight management. Post-surgery, some individuals consider additional support tools to sustain or enhance weight loss. One such option gaining attention is semaglutide, a GLP-1 receptor agonist initially approved for type 2 diabetes and chronic weight management.
For patients contemplating the use of semaglutide after gastric sleeve surgery, this guide elucidates how licensed providers assess its suitability within a comprehensive care strategy.
Semaglutide is a prescription medication that mimics the glucagon-like peptide-1 (GLP-1) hormone, aiding in the regulation of appetite and blood sugar levels. It is prescribed by licensed providers for individuals meeting specific medical criteria.
Gastric sleeve surgery involves reducing the size of the stomach to limit food intake, which alters appetite signals and establishes new patterns of eating, digestion, and satiety.
Post-surgery, individuals may experience changes in appetite, energy levels, or weight trends, prompting them to seek additional support. In consultation with a licensed provider, patients may discuss whether GLP-1 therapy could be appropriate.
Any decision regarding medication should follow a comprehensive evaluation, including assessments of medical history, current symptoms, and nutritional intake.
{{primary-cta}}
Common side effects of GLP-1 medications include nausea, bloating, and changes in bowel habits. For individuals who have undergone gastric sleeve surgery, these effects may be more pronounced and should be closely monitored.
Nutritional Intake
Appetite changes post-surgery can already reduce food intake. Medications that further suppress appetite should only be considered under the supervision of a licensed provider who can assess the impact on nutrient intake and hydration.
Semaglutide can influence how other medications are processed. Patients should provide their full medication list to their provider to evaluate potential interactions.
Most providers recommend waiting at least three to six months after gastric sleeve surgery before evaluating new medications. This period allows the body to adjust and enables providers to assess post-surgical progress.
The timing for any medication should be personalized by a licensed professional.
Medication is not a substitute for long-term care routines. Patients should continue to focus on:
{{primary-cta}}
Semaglutide is among several options that licensed providers may consider. Depending on a patient's needs and goals, providers may recommend different therapies or support strategies that align with their clinical profile.
Eden connects individuals with licensed medical professionals equipped to evaluate a wide range of treatment options.
For some, the conversation about semaglutide after gastric sleeve surgery may commence months post-operation. The appropriate approach varies for each individual and should always be guided by a licensed provider. Eden’s role is to facilitate access to these discussions by connecting patients with professionals who offer individualized care plans based on medical necessity.
This article is for educational purposes only and does not constitute medical advice. Eden does not provide or prescribe medications, manufacture treatments, or offer medical care. All care plans are determined by licensed, independent providers.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.
Semaglutide is not specifically approved for post-bariatric use. A licensed provider can determine its appropriateness based on your medical history.
Only a licensed provider can evaluate whether semaglutide is suitable for you, considering factors like timing, surgical recovery, and overall health.
Many providers wait three to six months post-surgery before evaluating new treatments, depending on patient recovery.
Side effects such as nausea or appetite suppression may affect nutritional intake. Regular check-ins with your care team are essential.
No. Eden connects patients to licensed providers.